Market Closed -
OTC Markets
14:25:36 2024-06-24 EDT
|
5-day change
|
1st Jan Change
|
0.0002
USD
|
+19,900.00%
|
|
0.00%
|
-90.91%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
238.8
|
232.6
|
146.8
|
206.6
|
100.2
|
30.6
|
Enterprise Value (EV)
2 |
230.4
|
227.3
|
142.5
|
170.5
|
81.25
|
38.28
|
P/E ratio
|
-19.2
x
|
-10.3
x
|
-5.26
x
|
-5.33
x
|
-2.47
x
|
-0.53
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
2,837,182,512
x
|
2,488,635,983
x
|
68,882,701,000
x
|
-
|
-
|
EV / Revenue
|
-
|
2,771,975,195
x
|
2,415,805,475
x
|
56,823,701,000
x
|
-
|
-
|
EV / EBITDA
|
-20.7
x
|
-11.3
x
|
-5.43
x
|
-4.29
x
|
-2.1
x
|
-0.97
x
|
EV / FCF
|
-42.3
x
|
-18.9
x
|
-7.97
x
|
-6.95
x
|
-3.68
x
|
-1.78
x
|
FCF Yield
|
-2.36%
|
-5.3%
|
-12.5%
|
-14.4%
|
-27.2%
|
-56.2%
|
Price to Book
|
38
x
|
54
x
|
22.8
x
|
5.25
x
|
4.65
x
|
-3.52
x
|
Nbr of stocks (in thousands)
|
3,991
|
4,500
|
5,063
|
6,709
|
8,214
|
12,593
|
Reference price
3 |
59.84
|
51.70
|
29.00
|
30.80
|
12.20
|
2.430
|
Announcement Date
|
3/20/18
|
3/21/19
|
3/30/20
|
3/17/21
|
3/17/22
|
3/16/23
|
1USD in Million2CAD in Million3USD Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
|
-
|
0.082
|
0.059
|
0.003
|
-
|
-
|
EBITDA
1 |
-11.11
|
-20.1
|
-26.26
|
-39.77
|
-38.78
|
-39.58
|
EBIT
1 |
-11.25
|
-20.33
|
-26.64
|
-40.12
|
-39.1
|
-40.27
|
Operating Margin
|
-
|
-24,795.12%
|
-45,144.07%
|
-1,337,233.33%
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-12.03
|
-21.94
|
-27.36
|
-34.86
|
-36.59
|
-37.99
|
Net income
1 |
-12.03
|
-21.94
|
-27.36
|
-34.86
|
-36.59
|
-37.99
|
Net margin
|
-
|
-26,750%
|
-46,381.36%
|
-1,161,833.33%
|
-
|
-
|
EPS
2 |
-3.112
|
-5.012
|
-5.511
|
-5.780
|
-4.931
|
-4.553
|
Free Cash Flow
1 |
-5.449
|
-12.06
|
-17.88
|
-24.52
|
-22.11
|
-21.51
|
FCF margin
|
-
|
-14,702.59%
|
-30,300.42%
|
-817,287.5%
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/20/18
|
3/21/19
|
3/30/20
|
3/17/21
|
3/17/22
|
3/16/23
|
Fiscal Period: December |
2020 Q3
|
2020 Q4
|
2021 Q1
|
2021 Q2
|
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
---|
Net sales
1 |
0.088
|
0.089
|
0.0834
|
0.0526
|
0.051
|
0.0446
|
0.0312
|
0.0434
|
0.1578
|
0.2111
|
EBITDA
1 |
-8.468
|
-10.27
|
-8.49
|
-9.15
|
-12.83
|
-14.57
|
-13.08
|
-12.41
|
-11.7
|
-14.67
|
EBIT
1 |
-8.415
|
-10.36
|
-8.49
|
-9.304
|
-12.91
|
-14.35
|
-13.31
|
-12.69
|
-12.1
|
-12.35
|
Operating Margin
|
-9,562.5%
|
-11,643.82%
|
-10,182.14%
|
-17,674.73%
|
-25,311.33%
|
-32,182.04%
|
-42,578.4%
|
-29,246.54%
|
-7,670.55%
|
-5,848.39%
|
Earnings before Tax (EBT)
1 |
-8.327
|
-9.596
|
-8.406
|
-9.323
|
-12.98
|
-14.95
|
-13.7
|
-12.64
|
-11.95
|
-11.91
|
Net income
1 |
-8.327
|
-9.596
|
-8.406
|
-9.323
|
-12.98
|
-14.95
|
-13.7
|
-12.64
|
-11.95
|
-11.91
|
Net margin
|
-9,462.5%
|
-10,782.02%
|
-10,082.14%
|
-17,710.45%
|
-25,460.12%
|
-33,527.6%
|
-43,845.06%
|
-29,134.79%
|
-7,570.55%
|
-5,639.24%
|
EPS
2 |
-1.300
|
-1.400
|
-1.210
|
-1.376
|
-1.617
|
-1.770
|
-1.681
|
-1.531
|
-1.471
|
-1.311
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/12/20
|
3/17/21
|
5/12/21
|
8/11/21
|
11/10/21
|
3/17/22
|
5/13/22
|
8/11/22
|
11/10/22
|
3/16/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
7.67
|
Net Cash position
1 |
8.37
|
5.35
|
4.3
|
36.2
|
19
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-0.1939
x
|
Free Cash Flow
1 |
-5.45
|
-12.1
|
-17.9
|
-24.5
|
-22.1
|
-21.5
|
ROE (net income / shareholders' equity)
|
-181%
|
-412%
|
-508%
|
-152%
|
-140%
|
-509%
|
ROA (Net income/ Total Assets)
|
-43.8%
|
-63.6%
|
-73.4%
|
-61.7%
|
-50.8%
|
-61.8%
|
Assets
1 |
27.48
|
34.49
|
37.28
|
56.46
|
71.96
|
61.49
|
Book Value Per Share
2 |
1.570
|
0.9600
|
1.270
|
5.870
|
2.620
|
-0.6900
|
Cash Flow per Share
2 |
3.700
|
3.300
|
2.780
|
6.910
|
4.700
|
2.220
|
Capex
1 |
0.39
|
2.19
|
0.48
|
0.44
|
1.4
|
1.07
|
Capex / Sales
|
-
|
2,664.63%
|
806.78%
|
14,733.33%
|
-
|
-
|
Announcement Date
|
3/20/18
|
3/21/19
|
3/30/20
|
3/17/21
|
3/17/22
|
3/16/23
|
|
1st Jan change
|
Capi.
|
---|
| -90.91% | 2.34K | | +23.13% | 52.73B | | +37.49% | 39B | | -8.73% | 38.52B | | +28.09% | 30.38B | | -12.26% | 26.39B | | +10.57% | 26.08B | | +45.05% | 14.15B | | +32.23% | 12.6B | | -6.56% | 11.51B |
Other Biotechnology & Medical Research
|